Valantine Hannah bought BBIO

March 10, 2026 · Form 4 insider transaction

Valantine Hannah bought 8,671 shares of BridgeBio Pharma, Inc. at $27.36 per share, a transaction worth $237.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.